In this study, researchers measured the psychological manifestations among patients with BCR-ABL-negative MPNs to determine the effects of anxiety, distress, and depression on symptom burden in this patient population.
An assessment of depression in patients before autologous or allogeneic HCT demonstrated that the condition impacts overall survival and risk of GVDH in patients with hematologic malignancies.
New evidence indicates that depression can impact cancer outcomes following chemotherapy.
An analysis of data from Danish women with early-stage breast cancer assessed women's risk of receiving nonguideline treatment for their disease if they had a prior diagnosis of depression or prior treatment with antidepressants.
Nearly one in five cancer survivors are taking medication for depression or anxiety years later.
Changes in depression symptoms over time are associated with differences in survival among patients with lung cancer, especially those with early stage disease.
Nearly 25% to 33% of family caregivers of patients with advanced cancers report high levels of anxiety and depression symptoms, as well as significant time providing care.
Treatment with methylphenidate is not effective for depression in SSRI-treated patients with advanced cancer in hospice or receiving palliative care.
Palliative Care-Led Support vs Usual Care: Not Significantly Different for Anxiety and Depression in Cancer Patients' Family MembersJuly 06, 2016
Palliative care-led informational and emotional support meetings do not reduce anxiety or depression symptoms and may increase posttraumatic stress disorder (PTSD) symptoms in family members of patients with chronic critical illness.
A recent study examined depression and anxiety among family caregivers of patients with incurable cancer and sought to identify factors linked to these symptoms.
Socioeconomic status and features of physical health rather than tumor characteristics were associated with symptoms of depression among long-term survivors of colorectal cancer.
Benefits of light therapy include both decreasing depressive symptoms and normalizing circadian rhythms in cancer survivors.
Depressive Symptoms Linked to Worse Survival Following Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive SurgeryFebruary 23, 2016
A study examined the relationship between depression and survival for patients undergoing hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery.
Hematopoietic cell transplantation (HCT)-related concerns at the time of hospital discharge predict increases in depression but not in anxiety.
Researchers observed significant changes in health-related quality of life (HRQoL), depression, and sexual function among patients with breast cancer receiving chemotherapy.
Depression is a significant predictor of 5-year survival and recurrence in patients with head and neck cancer. These findings represent one of the largest studies to report on the impact of depression on cancer survival.
Risk of death from all causes is 45% higher in women with breast cancer and a subsequent diagnosis of depression, according to a recent study. This finding could help identify those women most at risk for depression and in need of support.
Depression and antidepressant use may not be associated with increased risk of breast cancer.
Depression may increase the intensity of postoperative acute pain in women with breast cancer.
The USPSTF urges that primary care physicians regularly screen for depression in all adult patients (B recommendation).
Researchers have found that combined use of antidepressants and NSAID painkillers is associated with an increased risk of bleeding.
Depression in patients with brain cancer is easily overlooked by clinicians.
Women with breast cancer are at an increased long-term risk for developing first depression.
Music therapy improves anxiety, depression, pain, and fatigue in patients with cancer.
Patients diagnosed with breast cancer, head and neck cancer, and malignant melanoma are particularly at risk for disorders such as anxiety or depression.
Men with diagnosed depressive disorders are less likely to pursue definitive treatment options for prostate cancer and more likely to have poorer outcomes.
Two classes of antidepressants improve symptoms of depression in cancer patients, according to a comprehensive review of treatments.
Depressed men with a diagnosis of intermediate- or high-risk prostate cancer have worse overall outcomes.
Family members caring for patients with advanced cancer benefit from early initiation of phone-based training and support.
Depression and anxiety, not just inflammation, predict pain intensity and interference with daily life among women recovering from gynecologic cancer surgery.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|